Senior Director, Recombinant Protein Development, CSL Behring
Global Engage is pleased to announce the 2nd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, due to be held on 20th-21st May 2019 in Dublin, Ireland. Building upon the success of last year’s meeting, this conference will once again provide an interactive networking forum for bioprocessing experts to examine the novel solutions and strategies that will improve the efficiency of biotherapeutic development.
With a vibrant exhibition hall full of solution providers, showcasing their latest technologies and services, and a 40-strong speaker faculty comprising of individual presentations, roundtable sessions and senior-level panel discussions, this year’s meeting will provide the opportunity to discuss current manufacturing and analytical challenges.
Our full speaker panel can be found here
Professor and Principal, NIBRT, Ireland and Visiting Investigator, Bioprocessing Technology Institute, A*Star , Singapore
Chief Scientist, Global Biologics-Biotech Development and Project Coordinator, Bayer
Biopharmaceutical drug production has seen unparalleled growth in recent years and is now a core element of the pharmaceutical industry. However, there are still are a number of bottlenecks within the manufacturing process, which need to be overcome. With complex biotherapeutics and advanced therapies showing huge potential for the future of medicine, new technologies and strategies are needed to produce these drugs efficiently whilst maintaining the high quality and standards required for them to enter the market.
Not only shall this meeting look at the manufacturing processes and regulatory challenges for biologics and biosimilars, the Congress shall also feature a track dedicated to the complex manufacturing of cell and gene therapies. Attracting experts working in all areas of bioprocessing and process analytics, including cell line development, single-use technologies, continuous processing, automated systems, real-time monitoring, CMC/GMP practices, QbD strategies, purification optimisation, scale-down models and effective scale-up strategies, this conference will examine the latest developments in the technologies and methods used for biopharmaceutical production.